Mumbai-based paediatric behavioural health platform Butterfly Learnings has raised ₹65 crore ($7.6 million) in a Pre-Series B funding round led by Inflexor Ventures, giving the company fresh capital to expand its care network, strengthen its technology and AI capabilities, and scale its early autism screening solution. Existing investors Enzia Ventures, Insitor Impact Asia Fund and IIMA Ventures also participated in the round.
Founded by Dr Sonam Kothari and Dr Abhishek Sen, Butterfly Learnings operates a full-stack platform serving children with neurodevelopmental conditions including autism, ADHD and learning disabilities. The company currently operates 90 centres across 22 cities in India and plans to expand beyond Maharashtra while increasing partnerships with hospitals and paediatricians.
Butterfly Learnings Raises ₹65 Crore In Pre-Series B Funding
The latest round marks a significant capital infusion for Butterfly Learnings as it moves into its next phase of expansion.
Inflexor Ventures led the investment through its Fund III, while existing investors returned to participate. The fresh capital is expected to support both the company’s physical healthcare network and its technology-led initiatives.
Butterfly Learnings Funding Round At A Glance
| Parameter | Details |
|---|---|
| Company | Butterfly Learnings |
| Sector | Paediatric behavioural healthcare |
| Latest round | Pre-Series B |
| Funding raised | ₹65 crore |
| Dollar value | ~$7.6 million |
| Lead investor | Inflexor Ventures |
| Other investors | Enzia Ventures, Insitor Impact Asia Fund, IIMA Ventures |
| Founders | Dr Sonam Kothari, Dr Abhishek Sen |
| Current centres | 90+ |
| Cities | 22 |
| Key technology | Get SET Early |
| Screening technology | Eye-tracking based |
| Regulatory approval | CDSCO |
| Screening age | From 1 year |
| Key expansion | Beyond Maharashtra |
The company has not disclosed a valuation for the latest funding round in the sources reviewed.
Inflexor Ventures Leads The New Round
The investment gives Inflexor Ventures a larger role in Butterfly Learnings’ growth story.
Inflexor partner Pratip Mazumdar said the firm’s investment was driven by Butterfly Learnings’ clinical capabilities, execution and the data generated through its platform. The investment was made from Inflexor’s Fund III.
Existing investors Enzia Ventures, Insitor Impact Asia Fund and IIMA Ventures also participated, providing continued backing for the company.
Investor Structure
| Investor | Role In Latest Round |
|---|---|
| Inflexor Ventures | Lead investor |
| Enzia Ventures | Existing investor |
| Insitor Impact Asia Fund | Existing investor |
| IIMA Ventures | Existing investor |
The continued participation from existing investors indicates that Butterfly Learnings has retained support from its earlier institutional backers as it prepares for a larger expansion.
Butterfly Learnings Plans To Expand Beyond Maharashtra
A major portion of the new funding will go toward expanding Butterfly Learnings’ centre network beyond Maharashtra.
The company currently operates 90 centres across 22 cities in India, according to Entrackr. Other reports describe the network as more than 90 centres.
Current Footprint
| Metric | Current Scale |
|---|---|
| Centres | 90+ |
| Cities | 22 |
| Primary expansion focus | Beyond Maharashtra |
| Therapists | 350+, according to Inc42 |
| Training institute | Yes |
The company is therefore moving from an established regional network toward a broader national footprint.
Expansion Roadmap
Existing 90+ Centres
↓
Expand Beyond Maharashtra
↓
More Indian Cities
↓
Hospital + Paediatrician Partnerships
↓
Broader Neurodevelopmental Care Network
The company has not publicly specified the exact number of new centres or cities it plans to add with the latest funding.
Butterfly Learnings Combines Healthcare And Technology
Unlike a conventional therapy-centre network, Butterfly Learnings operates a broader platform combining multiple components of paediatric behavioural healthcare.
Its services include clinical therapy, diagnostics, inclusive schooling, digital therapeutics and technology-enabled interventions.
Butterfly Learnings’ Full-Stack Model
| Area | Role |
|---|---|
| Clinical therapy | Behavioural and developmental support |
| Diagnostics | Assessment of developmental conditions |
| Digital therapeutics | Technology-enabled interventions |
| Inclusive schooling | Education support |
| Technology | Data and digital care tools |
| Screening | Early identification |
| Therapist training | Workforce development |
The integrated model is intended to provide families with a more coordinated care pathway instead of requiring them to manage separate providers for different parts of a child’s care.
Get SET Early Is A Major Technology Focus
One of the company’s key differentiators is Get SET Early, an eye-tracking based autism screening technology.
Butterfly Learnings holds an exclusive global licence for the technology. Following CDSCO approval, the solution can screen children from one year of age.
Get SET Early At A Glance
| Feature | Details |
|---|---|
| Technology | Eye-tracking |
| Application | Autism screening |
| Licence | Exclusive global licence held by Butterfly Learnings |
| Regulatory approval | CDSCO |
| Screening age | 1 year and above |
| Planned distribution | Hospitals and paediatricians |
The company plans to increase the deployment of Get SET Early through hospitals and paediatricians rather than limiting the technology to its own centres.
Why Early Screening Is Important To Butterfly’s Model
The company is targeting a major challenge in neurodevelopmental healthcare: delays between recognising developmental concerns and obtaining appropriate assessment and intervention.
Butterfly Learnings and industry sources estimate that nearly 45 million children in India live with conditions such as autism spectrum disorder, ADHD and learning disabilities, while only a small proportion receive timely intervention.
Current Care Challenge
Developmental Concern
↓
Delayed Screening
↓
Delayed Diagnosis
↓
Fragmented Care
↓
Delayed Intervention
Butterfly’s strategy is to bring screening closer to routine paediatric care and then connect families with appropriate intervention services.
Butterfly Wants Hospitals And Paediatricians To Become Distribution Channels
The latest funding will allow Butterfly Learnings to scale Get SET Early through partnerships with hospitals and paediatricians.
This could give the company access to families earlier in the healthcare journey.
Screening Partnership Model
Hospital / Paediatrician
↓
Get SET Early Screening
↓
Early Identification
↓
Specialist Assessment
↓
Therapy / Intervention
↓
Ongoing Care
The company is therefore attempting to connect its screening technology with its broader behavioural healthcare network.
AI Will Become A Bigger Part Of Butterfly Learnings
Another major use of the ₹65 crore funding will be strengthening the company’s AI and digital capabilities.
Butterfly Learnings is looking to use technology to support more standardised and outcome-tracked care as it expands its physical network.
Butterfly’s Technology Strategy
Clinical Data
Screening Data
Therapy Outcomes
↓
Technology Platform
↓
AI Capabilities
↓
More Personalised / Standardised Care
The company has not disclosed the specific AI models or applications it plans to develop.
Therapist Training Is Another Key Priority
Scaling neurodevelopmental care requires not only physical centres and technology but also trained professionals.
Butterfly Learnings operates a therapist training institute and plans to expand its in-house therapist training programme with the new funding.
The company is also described as operating a BHCOE-accredited therapist training institute, with training based on behavioural healthcare standards.
Therapist Expansion Model
More Centres
↓
Higher Patient Demand
↓
Need For More Therapists
↓
Training Institute
↓
Larger Skilled Workforce
This workforce strategy could become increasingly important as Butterfly expands into new cities.
Butterfly Learnings Previously Raised ₹32 Crore
The Pre-Series B round comes more than two years after Butterfly Learnings’ previous major funding round.
According to Inc42, the company raised ₹32 crore in a Series A round, led by Insitor Impact Asia Fund and Enzia Ventures.
Butterfly Learnings Funding Timeline
| Round | Amount | Lead / Key Investors |
|---|---|---|
| Series A | ₹32 crore | Insitor Impact Asia Fund, Enzia Ventures |
| Pre-Series B | ₹65 crore | Inflexor Ventures + existing investors |
| Total reported | ~$13 million | Since inception |
Inc42 reports that Butterfly Learnings has raised approximately $13 million since inception following the latest funding.
Butterfly Learnings Reported Funding Rounds
Comparison of the company’s reported Series A and Pre-Series B funding rounds.₹0₹20₹40₹60₹80Series APre-Series B
The latest round is ₹65 crore; earlier Series A funding was reported at ₹32 crore.
The latest round is therefore just over twice the size of the previously reported ₹32 crore Series A.
Butterfly Learnings’ Revenue More Than Doubled
The company has also been growing its revenue, although losses have increased alongside expansion.
According to Inc42, Butterfly Learnings reported ₹15.5 crore in revenue in FY25, compared with ₹6.3 crore in the previous fiscal year. Its net loss increased to ₹13.3 crore from ₹6.3 crore.
Financial Snapshot
| Metric | Earlier FY | FY25 |
|---|---|---|
| Revenue | ₹6.3 crore | ₹15.5 crore |
| Revenue growth | — | ~146% |
| Net loss | ₹6.3 crore | ₹13.3 crore |
| Loss growth | — | ~111% |
Butterfly Learnings Revenue And Net Loss
Reported revenue and net loss for the earlier fiscal year and FY25.
Revenue
Net loss₹0₹5₹10₹15₹20Earlier FYFY25
Figures are based on Inc42’s reported financial data.
The numbers show that Butterfly Learnings is expanding rapidly, but the company is also continuing to invest heavily in its growth infrastructure.
Revenue Growth Has Come With Higher Losses
The company’s financial trajectory reflects a common pattern among healthcare startups operating physical networks.
Opening centres, hiring therapists, developing technology and building clinical infrastructure can require significant upfront expenditure.
In Butterfly’s case, revenue grew by approximately 146%, while the reported net loss increased by roughly 111%.
Growth Vs Profitability
Revenue
₹6.3 Cr
↓
₹15.5 Cr
Net Loss
₹6.3 Cr
↓
₹13.3 Cr
This makes the deployment of the new ₹65 crore important because the company will need to balance expansion with improving operating efficiency over time.
India’s Neurodevelopmental Care Market Has A Large Unmet Need
Butterfly Learnings is operating in a market where access to specialised behavioural healthcare remains uneven.
The company estimates that nearly 45 million children in India live with neurodevelopmental conditions such as ASD, ADHD and learning disabilities.
The company and investors point to delayed diagnosis, fragmented care pathways and a shortage of trained specialists as major barriers.
Market Opportunity
| Factor | Situation |
|---|---|
| Children affected | ~45 million estimated |
| Conditions | Autism, ADHD, learning disabilities |
| Key challenge | Delayed diagnosis |
| Healthcare gap | Shortage of trained specialists |
| Care model | Often fragmented |
| Butterfly strategy | Integrated care + technology |
The 45-million figure is an estimate cited by Butterfly and supporting reports rather than a directly measured count of diagnosed children.
Butterfly’s Integrated Care Model Could Improve Continuity
The company’s full-stack approach attempts to bring multiple services under one platform.
Instead of families separately navigating screening, diagnosis, therapy, education and digital interventions, Butterfly wants to connect these elements.
Integrated Care Journey
Screening
↓
Diagnostics
↓
Therapy
↓
Education Support
↓
Digital Therapeutics
↓
Outcome Tracking
This model could also create a larger proprietary dataset over time, which is one reason investors are interested in the company’s technology strategy.
Data Could Become A Strategic Advantage
As Butterfly expands its centres and screening programme, it will potentially collect more information about clinical assessments, therapy interventions and outcomes.
The company’s investor commentary specifically points to its clinical data and platform-generated information as part of the investment thesis.
Potential Data Flywheel
More Patients
↓
More Clinical Data
↓
Better Outcome Tracking
↓
Improved Technology
↓
More Standardised Care
↓
More Patients
The company has not publicly quantified the size of its data repository or disclosed how it intends to commercialise it.
The ₹65 Crore Round Gives Butterfly Multiple Growth Levers
Unlike a funding round focused solely on geographic expansion, Butterfly plans to deploy the new capital across several interconnected areas.
Capital Deployment
| Priority | Expected Use |
|---|---|
| Centre expansion | Enter markets beyond Maharashtra |
| AI | Strengthen technology capabilities |
| Digital platform | Improve technology infrastructure |
| Get SET Early | Scale autism screening |
| Hospitals | Build screening partnerships |
| Paediatricians | Expand screening access |
| Therapist training | Build specialist workforce |
This combination gives the company multiple ways to scale, but it also increases execution complexity.
Why Inflexor Is Betting On Butterfly Learnings
For Inflexor Ventures, Butterfly Learnings represents a healthcare platform where technology is being combined with clinical operations.
Partner Pratip Mazumdar highlighted the founders’ clinical capabilities, execution and the data generated through the platform as reasons behind the investment.
The investment therefore reflects a broader venture-capital interest in healthcare businesses that can combine physical care delivery, software, data and specialised clinical expertise.
Butterfly’s Investment Thesis
Clinical Expertise
Physical Network
Technology
AI
Clinical Data
↓
Scalable Neurodevelopmental Care Platform
The Bigger Picture
Butterfly Learnings’ ₹65 crore Pre-Series B round is significant because it combines the expansion of a physical healthcare network with a growing technology and AI strategy. The company already operates more than 90 centres across 22 cities and now plans to move beyond Maharashtra while expanding its partnerships with hospitals and paediatricians.
The company’s Get SET Early screening technology is another important part of the strategy. With CDSCO approval and the ability to screen children from one year of age, Butterfly wants to move early autism screening into hospitals and paediatric practices. If successful, that could connect earlier identification with the company’s broader therapy and intervention network.
Looking Ahead
Butterfly Learnings’ next phase will focus on turning its existing 90-plus-centre footprint into a broader national network while building the technology infrastructure needed to support that scale. The company will also need to expand its therapist workforce, develop hospital and paediatrician partnerships and increase adoption of Get SET Early.
The financial picture will be another key metric to watch. Butterfly’s revenue increased from ₹6.3 crore to ₹15.5 crore in the reported period, but its net loss also rose from ₹6.3 crore to ₹13.3 crore. The new ₹65 crore funding round gives the company substantial additional capital, but its long-term success will depend on whether it can convert network expansion, technology investment and earlier screening into sustainable growth and improved operating economics
Get the day’s top stories in your inbox
One concise email. No spam, unsubscribe anytime.
